Angela S. Mazzotta
Papers
1
Total Citations
20
H-Index
1
About
Dr. Angela S. Mazzotta is a leading virologist whose work centers on HIV vaccine development and the standardization of immunological assays for global clinical trials. Her most impactful contribution, the 2012 paper "An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials," has garnered 20 citations and addresses a critical bottleneck in the field: the need for reproducible, high-throughput tools to evaluate neutralizing antibody responses. By developing an automated system for producing Env-pseudotyped viruses, Dr. Mazzotta enabled more consistent and scalable assessments across international trial sites, directly supporting the prioritization of vaccine candidates. This work underscores her commitment to bridging laboratory innovation with real-world public health needs, particularly in resource-limited settings. Her research has been instrumental in advancing standardized protocols that reduce variability in immune monitoring, a key challenge in HIV vaccine efficacy trials. Dr. Mazzotta’s efforts have strengthened the infrastructure for global HIV vaccine research, making her a vital contributor to the ongoing fight against the pandemic.
Research Focus
Key Achievements
Top Papers
- 1